Fetal de novo heterozygous variant in the isocitrate dehydrogenase 1 gene associated with growth restriction, skeletal, cerebral and vascular anomalies
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6433 ↗At a glance
Fallbericht in Prenatal Diagnosis, 2023. Written by Clara Illi and 6 co-authors. Institution: Department of Obstetrics of Charité University Hospital, Berlin, Germany. Major MEDLINE topics: Isocitrate Dehydrogenase, Fetal Growth Retardation, Abnormalities, Multiple. Cited 1 times so far (Crossref); 6 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Germline pathogenic variants in isocitrate dehydrogenase 1 (IDH1) can lead to a rare neurodevelopmental disorder called metaphyseal chondromatosis with D‐2‐hydroxyglutaric aciduria, including severe skeletal and cerebral anomalies. To the best of our knowledge, no prenatal case of an IDH1 pathogenic variant has been reported in literature. Somatic sequence variants in IDH1/2 genes are described in distinct cancers, premalignant diseases and rare inherited metabolic disorders. Amniocentesis and further genetic testing including trio exome sequencing were performed due to suspicious findings on a second trimester routine prenatal ultrasound examination. The fetus was found to have growth restriction, cerebral abnormalities (ex vacuo hydrocephalus, cerebellar and vermian hypoplasia, corpus callosum dysgenesis), brachycephaly, narrow chest, persistent left superior vena cava, liver calcifications, hyperechogenic bowel, short tubular bones and joint contractures. A de novo heterozygous variant in the IDH1 gene was detected via trio exome sequencing. The prenatal diagnosis of a de novo pathogenic variant in IDH1 in a fetus with the described phenotype, obtained through trio exome sequencing, helped parents and providers with an informed decision making about pregnancy management.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Obstetrics of Charité University Hospital, Berlin, Germany.
- Prenatal Diagnosis Bergmannstrasse, Berlin, Germany.
ORCID profiles: Clara Illi, Josefine Koenigbauer
Cite
APA
Illi, C., Koenigbauer, J., Henrich, W., Fangmann, L., Reinhardt, C., Ossmann, S., & Weichert, A. (2023). Fetal de novo heterozygous variant in the isocitrate dehydrogenase 1 gene associated with growth restriction, skeletal, cerebral and vascular anomalies. Prenatal Diagnosis. https://doi.org/10.1002/pd.6433
Vancouver
Illi C, Koenigbauer J, Henrich W, Fangmann L, Reinhardt C, Ossmann S, et al. Fetal de novo heterozygous variant in the isocitrate dehydrogenase 1 gene associated with growth restriction, skeletal, cerebral and vascular anomalies. Prenatal Diagnosis. 2023. doi:10.1002/pd.6433
BibTeX
@article{Illi2023,
author = {Illi, Clara and Koenigbauer, Josefine and Henrich, Wolfgang and Fangmann, Laura and Reinhardt, Charlotte and Ossmann, Sophia and Weichert, Alexander},
title = {Fetal de novo heterozygous variant in the isocitrate dehydrogenase 1 gene associated with growth restriction, skeletal, cerebral and vascular anomalies},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6433}
}
EUVIMED